title: Golimumab trough levels, antidrug antibodies and clinical response in patients with rheumatoid arthritis treated in daily clinical practice.
authors.affiliation: Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands.
authors.forename: Eva L
authors.initials: EL
authors.lastname: Kneepkens
authors.affiliation: Department of Rheumatology, La Paz University Hospital, Madrid, Spain.
authors.forename: Chamaida
authors.initials: C
authors.lastname: Plasencia
authors.affiliation: Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands.
authors.forename: Charlotte Lm
authors.initials: CL
authors.lastname: Krieckaert
authors.affiliation: Immunology Unit, La Paz University Hospital, Madrid, Spain.
authors.forename: Dora
authors.initials: D
authors.lastname: Pascual-Salcedo
authors.affiliation: Sanquin Diagnostic Services, Amsterdam, The Netherlands.
authors.forename: Desiree
authors.initials: D
authors.lastname: van der Kleij
authors.affiliation: Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands Department of Rheumatology, VU University medical centre, Amsterdam, The Netherlands.
authors.forename: Michael T
authors.initials: MT
authors.lastname: Nurmohamed
authors.affiliation: Department of Rheumatology, La Paz University Hospital, Madrid, Spain.
authors.forename: M Teresa
authors.initials: MT
authors.lastname: López-Casla
authors.affiliation: Sanquin Diagnostic Services, Amsterdam, The Netherlands.
authors.forename: Roeland
authors.initials: R
authors.lastname: Wieringa
authors.affiliation: Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, The Netherlands.
authors.forename: Theo
authors.initials: T
authors.lastname: Rispens
authors.affiliation: Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, The Netherlands.
authors.forename: Gertjan
authors.initials: G
authors.lastname: Wolbink
mesh_terms: D000328:Adult; D000368:Aged; D000906:Antibodies / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000097:blood / Q000276:immunology* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000097:blood / Q000276:immunology* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy*; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D000906:Antibodies; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; C529000:golimumab
keywords: Anti-TNF; Pharmacokinetics; Rheumatoid Arthritis